Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
AstraZeneca
Colorcon
Dow

Last Updated: May 28, 2022

Investigational Drug Information for SP2086


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for SP2086?

SP2086 is an investigational drug.

There have been 17 clinical trials for SP2086. The most recent clinical trial was a Phase 2 trial, which was initiated on October 15th 2021.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Renal Insufficiency. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd. and [disabled in preview].

There are four US patents protecting this investigational drug and forty-seven international patents.

Recent Clinical Trials for SP2086
TitleSponsorPhase
Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 DiabetesJiangsu HengRui Medicine Co., Ltd.Phase 3
The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy VolunteersJiangsu HengRui Medicine Co., Ltd.Phase 1
The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes PatientsJiangsu HengRui Medicine Co., Ltd.Phase 1

See all SP2086 clinical trials

Clinical Trial Summary for SP2086

Top disease conditions for SP2086
Top clinical trial sponsors for SP2086

See all SP2086 clinical trials

US Patents for SP2086

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SP2086 See Plans and Pricing Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives, preparation process and medicinal use thereof Jiangsu Hengrui Medicine Co. Ltd. (Jiangsu, CN) Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai, CN) See Plans and Pricing
SP2086 See Plans and Pricing Pharmaceutical composition for treatment of type 2 diabetes Jiangsu Hengrui Medicine Co., Ltd. (Lianyungang, CN) See Plans and Pricing
SP2086 See Plans and Pricing Tetrahydro-imidazo[1,5-.alpha.] pyrazine derivatives, preparation process and medicinal use thereof Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu, CN) See Plans and Pricing
SP2086 See Plans and Pricing Salts of methyl (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,- 7,8-tetrahydro-imidazo[1,5-A]pyrazine-1-carboxylate Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu, CN) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for SP2086

Drugname Country Document Number Estimated Expiration Related US Patent
SP2086 Australia AU2008342461 2027-12-26 See Plans and Pricing
SP2086 Brazil BRPI0821440 2027-12-26 See Plans and Pricing
SP2086 Canada CA2706735 2027-12-26 See Plans and Pricing
SP2086 China CN101468988 2027-12-26 See Plans and Pricing
SP2086 China CN101641361 2027-12-26 See Plans and Pricing
SP2086 European Patent Office EP2230241 2027-12-26 See Plans and Pricing
SP2086 Spain ES2529435 2027-12-26 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
AstraZeneca
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.